Answers are grounded in this paper and cite their sources.
Background Artificial intelligence (AI) is increasingly applied in microbiology; however, its integration into probiotic development remains limited. Existing reviews have primarily focused on isolated applications, leaving a gap in understanding the broader technical bottlenecks across the probiotic development pipeline and how AI can systematically address them. Scope and approach This review adopts a bottleneck-oriented, stage-specific framework to evaluate the role of AI in probiotic development. The pipeline is structured into four key stages: mechanistic screening, stability screening, strain characterization, and product and process optimization. For each stage, major technical challenges are identified, and corresponding AI-driven strategies are critically assessed, with particular emphasis on data characteristics and analytical constraints. Key findings and conclusions AI demonstrates strong potential to overcome recurring challenges across the probiotic development pipeline. These include limitations associated with small-sample, high-dimensional, and heterogeneous datasets in mechanistic screening; complex interactions among multiple stress factors and labor-intensive workflows in stability screening; strain-level heterogeneity and incomplete functional annotation in strain characterization; and large experimental design spaces, nonlinear variable interactions, and limited condition-specific data in product and process optimization. This review links these bottlenecks to actionable AI strategies and proposes a stepwise, sequencing data-centered workflow to facilitate systematic AI integration. Overall, the study provides a practical roadmap for advancing AI-enabled probiotic research and development.
No takes yet. Share an insight, caveat, or question.
Im et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: